XKRX
035080
Market cap86mUSD
Jul 10, Last price
9,370.00KRW
1D
2.40%
1Q
-16.41%
Jan 2017
-62.67%
Name
Gradiant Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Gradiant Corporation and its subsidiaries conduct e-commerce operations across South Korea, Vietnam, China, and various international regions. The company's activities are structured into several segments: Holding Business, Industrial B2B E-Commerce Business, Bio Healthcare Business, and Other Business. Gradiant primarily dedicates its efforts to three core areas: life sciences and healthcare, environmental and energy solutions, and creative learning platforms. Its diverse offerings include electric vehicle charging services, organoid research, venture capital financing for the biotech industry, advertising solutions, and logistics agency support, in addition to an online creative education platform. The company is also involved in sourcing and distributing pharmaceutical drugs and medical supplies to hospitals, developing oncology treatments, and designing, manufacturing, and commercializing adhesive films for electronic devices like smartphones. Furthermore, it supplies MRO (Maintenance, Repair, and Operations) and industrial consumables via online channels. Gradiant also participates in investment ventures, consulting, and freight transportation brokerage and agency services. Founded in 1995 and based in Seoul, South Korea, the company was known as Interpark Co., Ltd. until it rebranded to Gradiant Corporation in February 2022.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||